NGRN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.968220E-01
Normal-vs-Stage2
2.871600E-01
Normal-vs-Stage3
9.998200E-01
Normal-vs-Stage4
4.029800E-01
Stage1-vs-Stage2
6.678400E-01
Stage1-vs-Stage3
2.230400E-01
Stage1-vs-Stage4
6.789200E-01
Stage2-vs-Stage3
2.235600E-01
Stage2-vs-Stage4
9.080200E-01
Stage3-vs-Stage4
4.524800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.831000E-01
Normal-vs-AfricanAmerican
1.643000E-01
Normal-vs-Asian
4.087800E-01
Caucasian-vs-AfricanAmerican
9.251800E-01
Caucasian-vs-Asian
8.269400E-01
AfricanAmerican-vs-Asian
8.240800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.765200E-01
Normal-vs-Female
3.093000E-01
Male-vs-Female
5.081200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.915830E-01
Normal-vs-Age(41-60Yrs)
1.198590E-01
Normal-vs-Age(61-80Yrs)
4.111200E-01
Normal-vs-Age(81-100Yrs)
2.536000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.966040E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.113810E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.689800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.835800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.910210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.135000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.075400E-01
Normal-vs-Daily Drinker
2.767000E-01
Normal-vs-Weekly Drinker
4.216000E-01
Normal-vs-Occasional Drinker
2.699800E-01
Normal-vs-Social Drinker
1.943240E-01
Non Drinker-vs-Daily Drinker
8.754600E-01
Non Drinker-vs-Weekly Drinker
5.729000E-01
Non Drinker-vs-Occasional Drinker
2.024400E-01
Non Drinker-vs-Social Drinker
8.401600E-01
Daily Drinker-vs-Weekly Drinker
4.197600E-01
Daily Drinker-vs-Occasional Drinker
2.785800E-01
Daily Drinker-vs-Social Drinker
7.123800E-01
Weekly Drinker-vs-Occasional Drinker
1.087190E-01
Weekly Drinker-vs-Social Drinker
5.804400E-01
Occasional Drinker-vs-Social Drinker
1.752640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.494600E-01
Normal-vs-Grade 2
6.241800E-02
Normal-vs-Grade 3
4.567500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.271000E-01
Grade 1-vs-Grade 3
7.299400E-01
Grade 1-vs-Grade 4
2.494600E-01
Grade 2-vs-Grade 3
7.993400E-01
Grade 2-vs-Grade 4
6.241800E-02
Grade 3-vs-Grade 4
4.567500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.349400E-01
Normal-vs-NonDiabetic
2.445400E-01
Diabetic-vs-NonDiabetic
8.160100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.160430E-02
Normal-vs-NoPancreatitis
3.299600E-01
Pancreatitis-vs-NoPancreatitis
1.644180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.397400E-01
Normal-vs-N1
2.706000E-01
N0-vs-N1
7.614800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.506190E-01
Normal-vs-TP53-NonMutant
4.488000E-01
TP53-Mutant-vs-TP53-NonMutant
7.161900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
